These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 11837043)
21. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731 [TBL] [Abstract][Full Text] [Related]
23. Panel: emerging issues in Canada's drug policy--implications for HIV prevention and health promotion for people who use drugs. Strike C; Elliott R; Nolin C HIV AIDS Policy Law Rev; 2009 Dec; 14(2):93-8. PubMed ID: 20225528 [TBL] [Abstract][Full Text] [Related]
24. Needle and syringe exchange programs in Amsterdam. Witteveen E; Schippers G Subst Use Misuse; 2006; 41(6-7):835-6. PubMed ID: 16809172 [No Abstract] [Full Text] [Related]
25. Qualitative evaluation of a peer-based needle syringe programme in Vietnam. Ngo AD; Schmich L; Higgs P; Fischer A Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971 [TBL] [Abstract][Full Text] [Related]
26. Needle exchange: friend or foe. Nedjat-Shokouhi B Focus; 2002 Feb; 17(3):1-4. PubMed ID: 11968159 [No Abstract] [Full Text] [Related]
27. Peer helpers' struggles to care for "others" who inject drugs. Dechman MK Int J Drug Policy; 2015 May; 26(5):492-500. PubMed ID: 25630481 [TBL] [Abstract][Full Text] [Related]
28. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. Drucker E; Lurie P; Wodak A; Alcabes P AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006 [No Abstract] [Full Text] [Related]
29. Community networks in chronic disease management. Pyne D Healthc Q; 2009; 12(4):80-4. PubMed ID: 20057233 [TBL] [Abstract][Full Text] [Related]
30. Rhode Island's Syringe Exchange Program (ENCORE). Latta ET Med Health R I; 2000 Jul; 83(7):216-8. PubMed ID: 10934826 [No Abstract] [Full Text] [Related]
31. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program. Shotsky WJ; Cooper JG; Klein SJ Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507 [No Abstract] [Full Text] [Related]
32. Learning about scale, measurement and community mobilisation: reflections on the implementation of the Avahan HIV/AIDS initiative in India. Wheeler T; Kiran U; Dallabetta G; Jayaram M; Chandrasekaran P; Tangri A; Menon H; Kumta S; Sgaier S; Ramakrishnan A; Moore J; Wadhwani A; Alexander A J Epidemiol Community Health; 2012 Oct; 66 Suppl 2():ii16-25. PubMed ID: 22945907 [TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of harm reduction. Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260 [TBL] [Abstract][Full Text] [Related]
36. [Reduction of drug abuse ... a true public health paradigm]. Provost F Perspect Infirm; 2005; 2(3):44-5. PubMed ID: 15686213 [No Abstract] [Full Text] [Related]
37. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study. Limbu B Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796 [TBL] [Abstract][Full Text] [Related]
38. Science versus politics: the need for supervised injection facilities in Montreal, Canada. Jozaghi E Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890 [No Abstract] [Full Text] [Related]
39. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles. Lenton S; Bevan J; Lamond T Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175 [TBL] [Abstract][Full Text] [Related]
40. Community mobilisation: myths and challenges. Jana S J Epidemiol Community Health; 2012 Oct; 66 Suppl 2():ii5-6. PubMed ID: 22745344 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]